DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for …
!["DiscGenics allogeneic disc progenitor cell therapy"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/07/Discgenics_IDCT_injection.jpg?resize=599%2C345&ssl=1)
!["DiscGenics allogeneic disc progenitor cell therapy"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/07/Discgenics_IDCT_injection.jpg?resize=599%2C345&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for …
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) …
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of …